MSC-Exos inhibit the secretion of TGF-β1 to reduce epithelial-endothelial mesenchymal transition and block the proliferation of mesangial cells induced by the MAPKs and PI3K/AKT/mTOR pathways, thus alleviating renal fibrosis (60). The gene discussed is AKT1; the disease is renal fibrosis.